This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Applied Research Systems Ars Holding N.v., Instituto Fermacologio Serono Spa. Active years: 1990-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-2003
Title: Fabrizio Martelli: Innovator in Medical Research
Introduction
Fabrizio Martelli is a notable inventor based in Rome, Italy. He has made significant contributions to the field of medical research, particularly in the area of treatments for endometriosis. With a total of 3 patents to his name, Martelli's work has the potential to impact many lives.
Latest Patents
One of his latest patents focuses on tumor necrosis factor antagonists and their use in endometriosis. This invention involves administering tumor necrosis factor antagonists in therapeutically effective doses to treat and/or prevent endometriosis. The antagonists are typically selected from several classes, with a preference for soluble TNF receptors. These antagonists are useful for the regression of endometriotic lesions and, when combined with other active ingredients, can help ameliorate related disorders such as infertility.
Career Highlights
Throughout his career, Fabrizio Martelli has worked with various esteemed organizations. Notably, he has been associated with Applied Research Systems Ars Holding N.V. and Instituto Farmacologico Serono S.p.A. His work in these companies has allowed him to advance his research and contribute to innovative medical solutions.
Collaborations
Martelli has collaborated with several professionals in his field, including Francesco Borrelli and Renato Mastrangeli. These collaborations have enriched his research and expanded the scope of his inventions.
Conclusion
Fabrizio Martelli is a distinguished inventor whose work in medical research, particularly regarding endometriosis, showcases his innovative spirit. His patents and collaborations reflect his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile